Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 12 trials

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 3 (1)

Trial Status

Recruiting6
Unknown2
Active Not Recruiting2
Enrolling By Invitation1
Not Yet Recruiting1

Clinical Trials (12)

Showing 12 of 12 trials
NCT07443774Recruiting

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

NCT07840534Not ApplicableNot Yet Recruiting

Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)

NCT06605261Not ApplicableActive Not Recruiting

Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine Therapy

NCT07190443Phase 3Recruiting

Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

NCT06765707Not ApplicableEnrolling By Invitation

Symptom Monitoring Using Patient-Report to Improve Medication Use

NCT06033287Recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

NCT06050109Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

NCT06754293Not ApplicableActive Not Recruiting

Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol

NCT06642948Not ApplicableRecruiting

AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial

NCT05628077Unknown

Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

NCT05305092Recruiting

Assessment of Brain Cognitive Impairment in Breast Cancer

NCT04389424Unknown

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

Showing all 12 trials

Research Network

Activity Timeline